Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Targeted Next-Generation Sequencing of TP53, BIRC3, NOTCH1, SF3B1, and ATM Identifies a Significant Proportion of Lower-Risk Chronic Lymphocytic Leukemia with Unfavorable Prognostic Indicators

Brian Kwok, MD, Aine Yung, MD, Prashanti Reddy, MD, Yin Xu, MD PhD, Alex Chan, MS, MBA, Derek Lyle, MD

Blood (2018) 132 (Supplement 1): 3131.

https://doi.org/10.1182/blood-2018-99-110888

Published: 2018

Journal Articles

CD5-Negative Mantle Cell Leukemia Shows Frequent 17p Deletion and Marrow Involvement Mimicking Marginal Zone Lymphoma

Yin Xu, MD PhD, Prashanti Reddy, MD, Xun Li, MD, Riem Badr, MD, Keming Lin, MD, Gang Xu, MD PhD, Bashar Dabbas, MD

Blood (2016) 128 (22): 1800.

https://doi.org/10.1182/blood.V128.22.1800.1800

Published: 2016

Journal Articles

Clinicopathologic Analysis of Calr Mutation Subtypes in Myeloproliferative Neoplasms

Yin Xu, MD PhD, Brian Kwok, MD, Aine Yung, MD, Rachel Flamholz, MD, Zhao Wu, MD PhD, Bashar Dabbas, MD, Prashanti Reddy, MD

Blood (2015) 126 (23): 2822.

https://doi.org/10.1182/blood.V126.23.2822.2822

Published: 2015

Journal Articles

Next-Generation Sequencing (NGS)-Based Profiling of Idiopathic Cytopenia of Undetermined Significance (ICUS) Identifies a Subset of Patients with Genomic Similarities to Lower-Risk Myelodysplastic Syndrome (MDS)

Brian Kwok, MD, Prashanti Reddy, MD, Keming Lin, MD, Rachel Flamholz, MD, Aine Yung, MD, Bashar Dabbas, MD, Matthew McGinniss, PhD, Shareef Nahas, PhD, Julie Kines, Yin Xu, MD PhD

Blood (2014) 124 (21): 166.

https://doi.org/10.1182/blood.V124.21.166.166

Published: 2014

Journal Articles

Next-Generation Sequencing Of ASXL1, TP53, RUNX1, EZH2, and ETV6 Identifies a Significant Proportion Of Lower-Risk Myelodysplastic Syndromes With Poor Prognostic Indicators

Brian Kwok, MD, Renee Mohrmann, MD, Kim Janatpour, MD, Yin Xu, MD, PhD, Matthew McGinniss, PhD, Aine Yung, MD, Hong Drum, MD, Keming Lin, MD, Julie Kines, Jeffrey Tasmin, Bashar Dabbas, MD

Blood (2013) 122 (21): 1552.

https://doi.org/10.1182/blood.V122.21.1552.1552

Published: 2013

Journal Articles

Chronic Myelomonocytic Leukemia With Preexisting Myelodysplastic Syndrome Or Myeloproliferative Neoplasm: Two Stages Of One Disease With Poor Prognosis

Yin Xu, MD, PhD, Aine Yung, MD, Brian Kwok, MD, Karen Macdonell, MD, Bashar Dabbas, MD, Prashanti Reddy, MD

Blood (2013) 122 (21): 1342.

https://doi.org/10.1182/blood.V122.21.1342.1342

Published: 2013

Journal Articles

FMC-7 Expression Identifies Phenotypically Atypical Chronic Lymphocytic Leukemia with Distinct Clinical and Molecular Genetic Features.

Prashanti Reddy, MD, Bashar Dabbas, MD, Maggie Gama, Thomas Kocher, Hong L. Drum, MD, Jesalyn Taylor, Yin Xu, MD, PhD

Blood (2012) 120 (21): 2478.

https://doi.org/10.1182/blood.V120.21.2478.2478

Published: 2012

NARROW

Targeted Next-Generation Sequencing of TP53, BIRC3, NOTCH1, SF3B1, and ATM Identifies a Significant Proportion of Lower-Risk Chronic Lymphocytic Leukemia with Unfavorable Prognostic Indicators

CD5-Negative Mantle Cell Leukemia Shows Frequent 17p Deletion and Marrow Involvement Mimicking Marginal Zone Lymphoma

Clinicopathologic Analysis of Calr Mutation Subtypes in Myeloproliferative Neoplasms

Next-Generation Sequencing (NGS)-Based Profiling of Idiopathic Cytopenia of Undetermined Significance (ICUS) Identifies a Subset of Patients with Genomic Similarities to Lower-Risk Myelodysplastic Syndrome (MDS)

Next-Generation Sequencing Of ASXL1, TP53, RUNX1, EZH2, and ETV6 Identifies a Significant Proportion Of Lower-Risk Myelodysplastic Syndromes With Poor Prognostic Indicators

Chronic Myelomonocytic Leukemia With Preexisting Myelodysplastic Syndrome Or Myeloproliferative Neoplasm: Two Stages Of One Disease With Poor Prognosis

FMC-7 Expression Identifies Phenotypically Atypical Chronic Lymphocytic Leukemia with Distinct Clinical and Molecular Genetic Features.

Email alerts

ASH Publications

American Society of Hematology

Targeted Next-Generation Sequencing of TP53, BIRC3, NOTCH1, SF3B1, and ATM Identifies a Significant Proportion of Lower-Risk Chronic Lymphocytic Leukemia with Unfavorable Prognostic Indicators

CD5-Negative Mantle Cell Leukemia Shows Frequent 17p Deletion and Marrow Involvement Mimicking Marginal Zone Lymphoma

Clinicopathologic Analysis of Calr Mutation Subtypes in Myeloproliferative Neoplasms

Next-Generation Sequencing (NGS)-Based Profiling of Idiopathic Cytopenia of Undetermined Significance (ICUS) Identifies a Subset of Patients with Genomic Similarities to Lower-Risk Myelodysplastic Syndrome (MDS)

Next-Generation Sequencing Of ASXL1, TP53, RUNX1, EZH2, and ETV6 Identifies a Significant Proportion Of Lower-Risk Myelodysplastic Syndromes With Poor Prognostic Indicators

Chronic Myelomonocytic Leukemia With Preexisting Myelodysplastic Syndrome Or Myeloproliferative Neoplasm: Two Stages Of One Disease With Poor Prognosis

FMC-7 Expression Identifies Phenotypically Atypical Chronic Lymphocytic Leukemia with Distinct Clinical and Molecular Genetic Features.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only